Key facts
- Notable investors include Arieli Group, NGT HealthCare II.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Anaconda Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Anaconda Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Anaconda Medical
Manufacturer of neurovascular occlusion devices designed for minimally invasive treatment of complex cerebral conditions. The company's platform utilizes a patented nitinol mesh that expands tridimensionally within blood vessels, allowing single-device deployment for large aneurysms, high-volume packing efficiency, microcatheter compatibility, and broader applications in vascular malformations, enabling healthcare providers to reduce procedural time, risk, and cost while improving patient outcomes.
- Sector
- Healthcare
- HQ
- Nazareth, Israel
- Website
- anacondamed.com/
- Ownership
- Privately Held (backing)
Anaconda Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Anaconda Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Anaconda Medical in its N-PORT filings yet. We sweep new filings monthly.